By Region North America Decentralized Clinical Trials Market North America accounts for 44.2% of the 2025 global decentralized clinical trials market and advances at a 13.8% CAGR, positioning the region as both the largest and among the most active development environments for DCT methodology globally
Accelerated biological aging, poor sleep architecture, declining skin elasticity, slow wound healing, reduced resilience, and patients who want to combine internal longevity support with visible tissue regeneration
Centrum Use and Progression of Age-Related Cataract in the Age-Related Eye Disease Study: A Propensity Score Approach
Due to the absence of regulatory oversight for research-only compounds, parameters such as purity, potency, and sterility can vary significantly across different laboratory suppliers
10.1016/j.cellsig.2007.12.013 Cell Signal